BioVie Awarded up to $13.1 Million in Funding From U.S. Department of Defense to Evaluate Bezisterim (Ne3107) for the Treatment of Long Covid
BioVie獲得了美國國防部高達1310萬美元的資助,用於評估Bezisterim(Ne3107)治療長期冠狀病毒的療法
BioVie Awarded up to $13.1 Million in Funding From U.S. Department of Defense to Evaluate Bezisterim (Ne3107) for the Treatment of Long Covid
BioVie獲得了美國國防部高達1310萬美元的資助,用於評估Bezisterim(Ne3107)治療長期冠狀病毒的療法
使用瀏覽器的分享功能,分享給你的好友吧